#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute respiratory distress syndrome Rhabdomyosarcoma Crohn's disease Acute leukaemia Epstein-Barr virus associated lymphoproliferative disorder Retinopathy proliferative Desmoplastic small round cell tumour Immune-mediated myositis Rheumatoid arthritis Paroxysmal nocturnal haemoglobinuria Hereditary angioedema with C1 esterase inhibitor deficiency Mitochondrial encephalomyopathy Pneumonia Neurodegenerative disorder Ependymoma More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Life with Disease Hairy cell leukaemia recurrent Mucopolysaccharidosis I – Life with Disease Alveolar rhabdomyosarcoma – Treatment Alternating hemiplegia of childhood – Diagnostics Mantle cell lymphoma stage II – Basic Information Hereditary angioedema – Trials in Disease Vascular malformation – Basic Information Ocular melanoma – Life with Disease Nephrotic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mycophenolic Acid Ngi226 SAR444336 Sulfur Hexafluoride Piperacillin Monohydrate 18F-Fludarabine Isaralgagene Civaparvovec Triamcinolone Hexacetonide GUAIACOL IPN01195 Mebendazole Satralizumab HLX43 Bidridistrogene Xeboparvovec Linagliptin Citicoline Sodium Pentoxifylline Olmesartan Medoxomil Atorvastatin Epirubicin More therapies…

    Learn about Your Condition

    Lung transplant Malignant oligodendroglioma Bronchostenosis Craniosynostosis SAPHO syndrome Obsessive-compulsive disorder Anaemia Vulvovaginal dryness Metastasis Hepatotoxicity Hyperchylomicronaemia Primary myelofibrosis Implantation complication Primary adrenal insufficiency Breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Regional Du Cancer De Montpellier

Institut Regional Du Cancer De Montpellier

208 Avenue Des Apothicaires, Montpellier, 34298, France

Want to learn more about this study or check if you can participate? Contact us.

  • Sacituzumab Tirumotecan in Recurrent or Metastatic Cervical Cancer After Platinum Chemotherapy and Anti-PD-L1 or Anti-PD-1 Therapy

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • H2-Receptor Antagonists
    • Irinotecan Hydrochloride
    • Tisotumab Vedotin
    Austria Belgium Bulgaria Denmark Finland France +9

  • Study of Lutetium (177Lu) Oxodotreotide, Carboplatin, Etoposide, and Atezolizumab in Newly Diagnosed Extensive Stage Small Cell Lung Cancer Patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Arginine Hydrochloride
    • Dotatate
    • Lutetium (177Lu) Oxodotreotide
    Austria Belgium Czechia France Germany Italy +2

  • Study of Tarlatamab and Durvalumab compared to Durvalumab alone for patients with extensive stage small cell lung cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Argipressin
    • Mannitol
    • Siltuximab
    Austria Belgium Bulgaria Czechia Denmark France +10

  • A Study of Raludotatug Deruxtecan for People with Gastrointestinal Cancers to Evaluate Safety and Effectiveness

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Raludotatug Deruxtecan
    France Spain

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Leuprorelin Acetate
    • Anastrozole
    • Camizestrant
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

  • Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Cervix carcinoma recurrent
    • Endometrial adenocarcinoma
    • Lung adenocarcinoma
    Investigated Drugs:
    • Bemarituzumab
    Austria Belgium Bulgaria Czechia Denmark Finland +9

  • Study of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Zolbetuximab
    • Folinic Acid
    • Capecitabine
    Belgium Czechia France Germany Italy Lithuania +5

  • Study of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • PUCOTENLIMAB
    France

  • Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Eribulin Mesylate
    • Capecitabine
    • Carboplatin
    Belgium France Germany Hungary Italy Poland +1

  • Study on Reducing Treatment Intensity for Patients with HPV-Positive Oropharyngeal Cancer Using Cisplatin and Carboplatin

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Oropharyngeal squamous cell carcinoma
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    France Germany
Previous Page
1 … 10 11 12 13 14 … 25
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!